MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 5381-5390 Newer>
The Motley Fool
January 26, 2009
Brian Orelli
Which One of These Is Not Like the Other? Bristol-Myers and Eli Lilly run into some comparability issues. mark for My Articles 736 similar articles
Entrepreneur
February 2009
Dennis Romero
DNA Testing: A Growth Market The barriers to entry are daunting, but the DNA market provides opportunities. mark for My Articles 79 similar articles
The Motley Fool
January 23, 2009
Brian Orelli
Intuitive Surgical Is Taking Cues From Warren Buffett Even with the paltry projected growth predicted in the short-term, Intuitive Surgical looks like a good long-term investment. mark for My Articles 108 similar articles
The Motley Fool
January 23, 2009
Robert Steyer
BAX to the Future After minding its own business, Baxter International starts thinking about acquisitions again. mark for My Articles 123 similar articles
The Motley Fool
January 23, 2009
Brian Orelli
Wyeth Isn't Cheap Enough for Pfizer The Wall Street Journal reports that Pfizer is in talks to acquire Wyeth for $60 billion or more. Should they do it? mark for My Articles 520 similar articles
The Motley Fool
January 22, 2009
Brian Orelli
Abbott Labs Thumbs Nose at Recession On a GAAP basis, Abbott Labs fourth-quarter earnings per share were up a whopping 27%, and even better, the double-digit increases don't look like they're going to stop anytime soon. mark for My Articles 483 similar articles
The Motley Fool
January 21, 2009
Brian Orelli
Pharma Foe Speaks Up for Investors Some good ideas for President Obama's new Food and Drug Administration chief that would benefit investors in drug companies. mark for My Articles 688 similar articles
The Motley Fool
January 21, 2009
Brian Orelli
A Copycat on the Prowl Teva Pharmaceutical announces it is partnering with Lonza to develop generic versions of biologics, called biosimilars, or follow-on biologics. mark for My Articles 486 similar articles
The Motley Fool
January 20, 2009
Brian Orelli
Johnson & Johnson Nimble ... for Now The health-care giant reports increasing earnings, despite falling revenue. mark for My Articles 683 similar articles
The Motley Fool
January 20, 2009
Anders Bylund
Foolish Forecast: Grab Intuitive Surgical While It's Cheap In advance of earnings let's take a look at how medical robotics maker Intuitive Surgical stacks up against some of its peers and competitors. mark for My Articles 206 similar articles
<Older 5381-5390 Newer>    Return to current articles.